688 related articles for article (PubMed ID: 19037880)
1. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
Flachs P; Rossmeisl M; Bryhn M; Kopecky J
Clin Sci (Lond); 2009 Jan; 116(1):1-16. PubMed ID: 19037880
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
Martínez-Fernández L; Laiglesia LM; Huerta AE; Martínez JA; Moreno-Aliaga MJ
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):24-41. PubMed ID: 26219838
[TBL] [Abstract][Full Text] [Related]
3. n-3 PUFA: bioavailability and modulation of adipose tissue function.
Kopecky J; Rossmeisl M; Flachs P; Kuda O; Brauner P; Jilkova Z; Stankova B; Tvrzicka E; Bryhn M
Proc Nutr Soc; 2009 Nov; 68(4):361-9. PubMed ID: 19698199
[TBL] [Abstract][Full Text] [Related]
4. n-3 fatty acids modulate adipose tissue inflammation and oxidative stress.
Fan C; Zirpoli H; Qi K
Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):124-32. PubMed ID: 23222801
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
[TBL] [Abstract][Full Text] [Related]
6. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma.
Chambrier C; Bastard JP; Rieusset J; Chevillotte E; Bonnefont-Rousselot D; Therond P; Hainque B; Riou JP; Laville M; Vidal H
Obes Res; 2002 Jun; 10(6):518-25. PubMed ID: 12055328
[TBL] [Abstract][Full Text] [Related]
7. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
[TBL] [Abstract][Full Text] [Related]
8. Regulation of adipokine secretion by n-3 fatty acids.
Moreno-Aliaga MJ; Lorente-Cebrián S; Martínez JA
Proc Nutr Soc; 2010 Aug; 69(3):324-32. PubMed ID: 20540825
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
11. n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanisms.
Siriwardhana N; Kalupahana NS; Fletcher S; Xin W; Claycombe KJ; Quignard-Boulange A; Zhao L; Saxton AM; Moustaid-Moussa N
J Nutr Biochem; 2012 Dec; 23(12):1661-7. PubMed ID: 22475809
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review.
Lombardo YB; Chicco AG
J Nutr Biochem; 2006 Jan; 17(1):1-13. PubMed ID: 16214332
[TBL] [Abstract][Full Text] [Related]
13. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes.
Tishinsky JM; Ma DW; Robinson LE
Obesity (Silver Spring); 2011 Feb; 19(2):262-8. PubMed ID: 20814411
[TBL] [Abstract][Full Text] [Related]
14. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.
Nettleton JA; Katz R
J Am Diet Assoc; 2005 Mar; 105(3):428-40. PubMed ID: 15746832
[TBL] [Abstract][Full Text] [Related]
15. Early and prolonged intake of partially hydrogenated fat alters the expression of genes in rat adipose tissue.
Duque-Guimarães DE; de Castro J; Martinez-Botas J; Sardinha FL; Ramos MP; Herrera E; do Carmo Md
Nutrition; 2009; 25(7-8):782-9. PubMed ID: 19251397
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
17. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
18. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers.
Judé S; Roger S; Martel E; Besson P; Richard S; Bougnoux P; Champeroux P; Le Guennec JY
Prog Biophys Mol Biol; 2006; 90(1-3):299-325. PubMed ID: 16005051
[TBL] [Abstract][Full Text] [Related]
19. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
Maurin AC; Chavassieux PM; Meunier PJ
Calcif Tissue Int; 2005 May; 76(5):385-92. PubMed ID: 15868283
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat.
Flachs P; Horakova O; Brauner P; Rossmeisl M; Pecina P; Franssen-van Hal N; Ruzickova J; Sponarova J; Drahota Z; Vlcek C; Keijer J; Houstek J; Kopecky J
Diabetologia; 2005 Nov; 48(11):2365-75. PubMed ID: 16205884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
